Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter M. Castleman appears in our data through filings on Caris Life Sciences, Inc. shares, published by SEC (Form 4). The record holds 5 filings, for trades running from 27 February 2025 to 14 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 14 August 2026, reports a share grant in Caris Life Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations